SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 8, 2018-- Veracyte, Inc. (Nasdaq: VCYT) announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis
Study findings reported at the American Thyroid Association Annual Meeting SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 6, 2018-- Veracyte, Inc. (Nasdaq: VCYT) announced today that new findings from six studies reinforcing the “real world” performance of the next-generation Afirma Genomic
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 27, 2018-- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson , chairman and chief executive officer, will present at the 2018 Cantor Fitzgerald Global Healthcare Conference on Tuesday, October 2, 2018 , at 1:05 p.m.
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 27, 2018-- Veracyte, Inc. (NASDAQ: VCYT) announced that new data highlighting the ability of the Percepta Bronchial Genomic Classifier to reduce unnecessary invasive procedures in lung cancer diagnosis will be shared in an oral presentation at
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 26, 2018-- Veracyte, Inc. (Nasdaq: VCYT) today announced that findings from six studies will be presented at the 88 th Annual Meeting of the American Thyroid Association (ATA), demonstrating the “real world” performance of the Afirma Genomic
First Test for Improved IPF Diagnosis Receives Draft Local Coverage Determination Through the MolDx Program SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 30, 2018-- Veracyte, Inc. (Nasdaq: VCYT) announced that it has received a draft Medicare local coverage determination (LCD) for the Envisia
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 30, 2018-- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson , chairman and chief executive officer, will present at the Morgan Stanley 16th Annual Global Healthcare Conference on Thursday, September 13, 2018 at 2:55 p.m.
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 29, 2018-- Veracyte, Inc. (Nasdaq: VCYT) today announced that the company has named Angeline (“Angie”) McCabe as vice president, investor relations and corporate communications, effective immediately. In this role, Ms.
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 30, 2018-- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson , chairman and chief executive officer, will present at the Canaccord Genuity 38th Annual Growth Conference on Thursday, August 9, 2018 at 11:30 a.m.
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 30, 2018-- Veracyte, Inc. (Nasdaq: VCYT) announced today the closing of its public offering of 5,750,000 shares of common stock, including 750,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price
The information in our press releases and webcasts should be considered accurate only as of the date of the press release or presentation. We disclaim any obligation to supplement or update the information in these press releases or presentations.
